Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-105076
Filing Date
2026-03-13
Accepted
2026-03-13 08:10:55
Documents
101
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K svra-20251231.htm   iXBRL 10-K 3091091
2 EX-4.19 svra-ex4_19.htm EX-4.19 33646
3 EX-4.22 svra-ex4_22.htm EX-4.22 147144
4 EX-10.39 svra-ex10_39.htm EX-10.39 576513
5 EX-10.40 svra-ex10_40.htm EX-10.40 192562
6 EX-10.41 svra-ex10_41.htm EX-10.41 245087
7 EX-23.1 svra-ex23_1.htm EX-23.1 4371
8 EX-31.1 svra-ex31_1.htm EX-31.1 15620
9 EX-31.2 svra-ex31_2.htm EX-31.2 15698
10 EX-32.1 svra-ex32_1.htm EX-32.1 14119
11 GRAPHIC img4852942_0.jpg GRAPHIC 5538
12 GRAPHIC img4852942_1.gif GRAPHIC 40891
13 GRAPHIC img4852942_2.jpg GRAPHIC 267225
14 GRAPHIC img4852942_3.jpg GRAPHIC 61664
15 GRAPHIC img4852942_4.gif GRAPHIC 31850
  Complete submission text file 0001193125-26-105076.txt   15869438

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT svra-20251231.xsd EX-101.SCH 1954076
104 EXTRACTED XBRL INSTANCE DOCUMENT svra-20251231_htm.xml XML 2519369
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32157 | Film No.: 26750136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)